The MUC4 membrane-bound mucin regulates esophageal cancer cell proliferation and migration properties: Implication for S100A4 protein

被引:11
|
作者
Bruyere, Emilie [1 ,2 ]
Jonckheere, Nicolas [1 ,2 ]
Frenois, Frederic [1 ,2 ]
Mariette, Christophe [1 ,2 ,3 ]
Van Seuningen, Isabelle [1 ,2 ]
机构
[1] INSERM, Jean Pierre Aubert Res Ctr, UMR837, Team Mucins Epithelial Differentiat & Carcinogene, F-59045 Lille, France
[2] Univ Lille Nord France, F-59045 Lille, France
[3] Univ Hosp Claude Huriez, Dept Digest & Oncol Surg, F-59045 Lille, France
关键词
Esophagus; Adenocarcinoma; Mucin; MUC4; S100A4; GASTROESOPHAGEAL-REFLUX DISEASE; BARRETTS-ESOPHAGUS; GENE-EXPRESSION; OVARIAN-CANCER; BILE-ACIDS; METASTASIS; THERAPY; ADENOCARCINOMA; EPIDEMIOLOGY; PROGNOSIS;
D O I
10.1016/j.bbrc.2011.08.095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MUC4 is a membrane-bound mucin known to participate in tumor progression. It has been shown that MUC4 pattern of expression is modified during esophageal carcinogenesis, with a progressive increase from metaplastic lesions to adenocarcinoma. The principal cause of development of esophageal adenocarcinoma is the gastro-esophageal reflux, and MUC4 was previously shown to be upregulated by several bile acids present in reflux. In this report, our aim was thus to determine whether MUC4 plays a role in biological properties of human esophageal cancer cells. For that stable MUC4-deficient cancer cell lines (shMUC4 cells) were established using a shRNA approach. In vitro (proliferation, migration and invasion) and in vivo (tumor growth following subcutaneous xenografts in SCID mice) biological properties of shMUC4 cells were analyzed. Our results show that shMUC4 cells were less proliferative, had decreased migration properties and did not express S100A4 protein when compared with MUC4 expressing cells. Absence of MUC4 did not impair shMUC4 invasiveness. Subcutaneous xenografts showed a significant decrease in tumor size when cells did not express MUC4. Altogether, these data indicate that MUC4 plays a key role in proliferative and migrating properties of esophageal cancer cells as well as is a tumor growth promoter. MUC4 mucin appears thus as a good therapeutic target to slow-down esophageal tumor progression. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:325 / 329
页数:5
相关论文
共 45 条
  • [31] The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells
    Yuan, Tein-Ming
    Liang, Ruei-Yue
    Hsiao, Nai-Wan
    Chuang, Show-Mei
    ONCOLOGY REPORTS, 2014, 32 (06) : 2307 - 2318
  • [32] RPS12-specific shRNA inhibits the proliferation, migration of BGC823 gastric cancer cells with S100A4 as a downstream effector
    Chen, Danqi
    Zhang, Ruixiu
    Shen, Wei
    Fu, Hao
    Liu, Shanshan
    Sun, Kailai
    Sun, Xiuju
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 42 (05) : 1763 - 1769
  • [33] S100A4 promotes cell migration and growth through focal adhesion kinase and Src mediated dual signaling pathways in pancreatic cancer cells
    Cai, Guoqiang
    Kerr, Elizabeth H.
    Hu, Meng
    Yang, Youfeng
    Buchsbaum, Donald J.
    Grizzle, William E.
    Ding, Qiang
    CANCER RESEARCH, 2013, 73 (08)
  • [34] miR-3189-3p Mimics Enhance the Effects of S100A4 siRNA on the Inhibition of Proliferation and Migration of Gastric Cancer Cells by Targeting CFL2
    Bian, Yue
    Guo, Junfu
    Qiao, Linlin
    Sun, Xiuju
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (01)
  • [35] Arctiin Inhibits Cervical Cancer Cell Migration and Invasion through Suppression of S100A4 Expression via PI3K/Akt Pathway
    Lee, Chung-Yuan
    Hsin, Min-Chieh
    Chen, Pei-Ni
    Lin, Chiao-Wen
    Wang, Po-Hui
    Yang, Shun-Fa
    Hsiao, Yi-Hsuan
    PHARMACEUTICS, 2022, 14 (02)
  • [36] S100A4 influences cancer stem cell-like properties of MGC803 gastric cancer cells by regulating GDF15 expression
    Guo, Junfu
    Bian, Yue
    Wang, Yu
    Chen, Lisha
    Yu, Aiwen
    Sun, Xiuju
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (02) : 559 - 568
  • [37] Dihydromyricetin Inhibited Migration and Invasion by Reducing S100A4 Expression through ERK1/2/β-Catenin Pathway in Human Cervical Cancer Cell Lines
    Hsin, Min-Chieh
    Hsiao, Yi-Hsuan
    Chen, Pei-Ni
    Lin, Chiao-Wen
    Wang, Po-Hui
    Yang, Shun-Fa
    Lee, Chung-Yuan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [38] S100A4 and Bone Morphogenetic Protein-2 Codependently Induce Vascular Smooth Muscle Cell Migration via Phospho-Extracellular Signal-Regulated Kinase and Chloride Intracellular Channel 4
    Spiekerkoetter, Edda
    Guignabert, Christophe
    Perez, Vinicio de Jesus
    Alastalo, Tero-Pekka
    Powers, Janine M.
    Wang, Lingli
    Lawrie, Allan
    Ambartsumian, Noona
    Schmidt, Ann-Marie
    Berryman, Mark
    Ashley, Richard H.
    Rabinovitch, Marlene
    CIRCULATION RESEARCH, 2009, 105 (07) : 639 - U37
  • [39] Thapsigargin, Inhibitor of Sarco-Endoplasmic Ca2+-ATPase, Effectively Suppresses the Expression of S100A4 Protein in Human Breast Cancer Cell Line
    Kotnova, A. P.
    Lyanova, B. M.
    Dukhanina, E. A.
    Portseva, T. N.
    Ilyin, Yu. V.
    Georgieva, S. G.
    Stepchenko, A. G.
    Pankratova, E. V.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2019, 486 (01) : 181 - 183
  • [40] Thapsigargin, Inhibitor of Sarco-Endoplasmic Ca2+-ATPase, Effectively Suppresses the Expression of S100A4 Protein in Human Breast Cancer Cell Line
    A. P. Kotnova
    B. M. Lyanova
    E. A. Dukhanina
    T. N. Portseva
    Yu. V. Ilyin
    S. G. Georgieva
    A. G. Stepchenko
    E. V. Pankratova
    Doklady Biochemistry and Biophysics, 2019, 486 : 181 - 183